| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |